Since ACE2 circulating levels were increased in the ICU group compared to the non-ICU and control group, both at mRNA and protein levels (Figures 5, 1B), we then tested the effect of full length ACE2 expression on the infection capacity of SARS-CoV-2. The gene discussed is ACE2; the disease is infection.